Search over 3,000 reports

    Imusera- Drug Insight, 2017

    Imusera- Drug Insight, 2017
    Date: Jan, 2018
    Type: Pharmaceutical Industry Report
    Pages: 35
    Geography: Global
    Delivery Timeline: 48 hours
    SKU: DIDI0178
    "Imusera - Drug Insight, 2018" report by DelveInsight provides comprehensive information of the drug, Imusera. It includes Imusera`s overview, mechanism, clinical trials, regulatory milestones, deals & partnerships. It further provides Imusera`s patents (US & EU)* and its API manufacturers details in the United States, Europe, China and India.* It also features the historical and forecasted sales of Imusera till 2020. The report also throws light on Imusera`s market competition and emerging therapies in the same space as Imusera. A SWOT analysis of Imusera is also featured.
    * Depending on information availability

    Methodology
    Data used in the report are sourced primarily from internal databases, primary and secondary research and in-house analysis by DelveInsight’s team of industry experts.
    Information and data from the secondary sources have been obtained from various printable and non-printable sources like search engines, news websites, global regulatory authorities websites, trade journals, white papers, magazines, books, trade associations, industry associations, industry portals and access to available databases.

    Scope of the report
    • A comprehensive product overview including product description, regulatory milestones, clinical trials, deals and partnerships, have been elaborated in this report
    • Patent information around Imusera in United States (US) and Europe (EU) has been highlighted
    • API manufacturers for Imusera in United States, Europe, China and India
    • The report contains historical and forecasted sales for Imusera till 2020
    • Comprehensive coverage of the emerging therapies (Phase III) in the space where Imusera operates including their product description, research and development activities, collaborations and licensing deals, drug mechanism and chemical information
    • The report also features the SWOT analysis of Imusera

    Reasons to Buy
    • Establish a comprehensive understanding of the drug, Imusera
    • Access to Imusera`s API manufacturers details to devise API procurement strategy for generic development
    • Plan developmental timelines around Imusera`s patents for the major markets- US and EU
    • Understand Imusera`s current and future growth through its historical and forecasted sales
    • Identify and understand the current in-market competitors for Imusera
    • Identify the product attributes and use it for target finding, drug repurposing, and precision medicine
    • Identify and plan ahead for prospective emerging players and their products operating in the same space as Imusera
    • Identify opportunities in the same area as Imusera with DelveInsight`s SWOT analysis
    1. Report Introduction
    2. Imusera - Overview
    • Product Description
    • Route of Synthesis
    • Mechanism of Action
    • Pharmacology
    • Pharmacodynamics
    • Pharmacokinetics
    • Adverse Reactions
    • Clinical Trials
    • Regulatory Milestones
    • Product Development Activities
    3. Global API Manufacturers
    • United States
    • Europe
    • China
    • India
    4. Product Details
    • United States
    • Europe
    5. Imusera Global Sales Assessment
    • Historical Global Sales
    • Forecasted Global Sales
    6. Patent Details
    7. Market Competition
    8. Emerging Therapies
    8.1. Drug name: Company name
    • Product Description
    • Research & Development
    • Product Development Activities
    Other product profiles in the detailed report…..
    9. SWOT Analysis
    Appendix
    Methodology
    Consulting Services
    About DelveInsight
    Contact Us
    Disclaimer
    Note: Certain sections of the table of contents would vary according to the availability of information
    Table 1: Imusera, Description
    Table 2: API Manufacturers Region wise
    Table 3: API Manufacturers for United States
    Table 4: API Manufacturers for Europe
    Table 5: API Manufacturers for China
    Table 6: API Manufacturers for India
    Table 7: Imusera Product Details, United States
    Table 8: Imusera Product Details, Europe
    Table 9: Imusera, Historical Global Sales till 2017 (in million USD)
    Table 10: Imusera, Forecasted Global Sales from 2018-2020 (in million USD)
    Table 11: Patent Details: Imusera
    Table 12: Imusera Major Competitors
    Table 13: Emerging Therapies
    Figure 1: Imusera
    Figure 2: Imusera, Historical Global Sales till 2017 (in million USD)
    Figure 3: Imusera, Forecasted Global Sales from 2018-2020 (in million USD)
    Figure 4: Patent Details: Imusera
    Figure 5: API Manufacturers Region wise
    Imusera

    Imusera Marketed Drugs Overview

    Imusera Market Assessment

    Imusera API Manufacturers/ Active Pharmaceutical Ingredients Manufacturers

    Imusera US DMF

    Imusera US Drug Master Files

    Imusera Active Substance Master File/ EUDMF

    Imusera Generic players

    Imusera Patent Expiration

    Imusera Patent Exclusivity

    Imusera API Manufacturers

    Imusera Global Forecasted Sales Figure

    Imusera API Route of Synthesis

    Imusera Market sales

    Imusera SWOT Analysis

    Imusera Pipeline

    • Single User License
      (20% Off)
      $1,000.00
    • Site License
      (30% Off)
      $2,000.00
    • Global License
      (40% Off)
      $3,000.00

    Contact Us

    Phone
    +91-11-45689769, +91 9650213330

    Email
    info@delveinsight.com

    Address
    New Delhi-110075, India

    Latest Tweets

    • Copyright © 2017 Delveinsight.
    • Sitemap